1. Home
  2. REPL vs FAX Comparison

REPL vs FAX Comparison

Compare REPL & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • FAX
  • Stock Information
  • Founded
  • REPL 2015
  • FAX 1986
  • Country
  • REPL United States
  • FAX United States
  • Employees
  • REPL N/A
  • FAX N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • FAX Investment Managers
  • Sector
  • REPL Health Care
  • FAX Finance
  • Exchange
  • REPL Nasdaq
  • FAX Nasdaq
  • Market Cap
  • REPL 816.4M
  • FAX 714.6M
  • IPO Year
  • REPL 2018
  • FAX N/A
  • Fundamental
  • Price
  • REPL $11.05
  • FAX $15.65
  • Analyst Decision
  • REPL Strong Buy
  • FAX
  • Analyst Count
  • REPL 4
  • FAX 0
  • Target Price
  • REPL $17.00
  • FAX N/A
  • AVG Volume (30 Days)
  • REPL 488.6K
  • FAX 833.6K
  • Earning Date
  • REPL 11-12-2024
  • FAX 01-01-0001
  • Dividend Yield
  • REPL N/A
  • FAX 12.09%
  • EPS Growth
  • REPL N/A
  • FAX N/A
  • EPS
  • REPL N/A
  • FAX N/A
  • Revenue
  • REPL N/A
  • FAX N/A
  • Revenue This Year
  • REPL N/A
  • FAX N/A
  • Revenue Next Year
  • REPL $469.74
  • FAX N/A
  • P/E Ratio
  • REPL N/A
  • FAX N/A
  • Revenue Growth
  • REPL N/A
  • FAX N/A
  • 52 Week Low
  • REPL $4.92
  • FAX $2.33
  • 52 Week High
  • REPL $12.97
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • REPL 43.04
  • FAX 30.27
  • Support Level
  • REPL $10.57
  • FAX $15.73
  • Resistance Level
  • REPL $12.73
  • FAX $16.12
  • Average True Range (ATR)
  • REPL 0.67
  • FAX 0.27
  • MACD
  • REPL -0.16
  • FAX -0.07
  • Stochastic Oscillator
  • REPL 20.00
  • FAX 3.62

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities, and others.

Share on Social Networks: